Synapse

← Chinese Medical Journal - Pulmonary and Critical Care Medicine

Papers in Chinese Medical Journal - Pulmonary and Critical Care Medicine

Page 2 · newest first

  1. Integrating tobacco control into China's health management: Strategies for healthier ChinaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  2. Understanding myofibroblast origin in the fibrotic lungChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  3. Overcoming EGFR-TKI resistance by targeting the tumor microenvironmentChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  4. Patterns and trends in asthma incidence rates in main Asian and Western countries and their prediction to 2030Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  5. Burden of RSV among inpatients with lower respiratory tract infection under 5 years of age: A 10-year retrospective study in Southwest China from 2009 to 2019Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  6. Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics developmentChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  7. Interventional pulmonology for chronic inflammatory airway diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  8. Evolution of transbronchial needle aspiration needles: Over the last half centuryChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  9. Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndromeChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  10. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future directionChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  11. Association of ratios of visceral fat area/subcutaneous fat area and muscle area/standard body weight at T12 CT level with the prognosis of acute respiratory distress syndromeChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  12. Prevalence of nicotine dependence among smokers aged 40 years and older in ChinaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  13. Cell–cell interactions and communication dynamics in lung fibrosisChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  14. Single nucleotide variants in lung cancerChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  15. Understanding cachexia and its impact on lung cancer and beyondChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  16. Emerging role of cellular senescence in normal lung development and perinatal lung injuryChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  17. Dysregulated bidirectional epithelial–mesenchymal crosstalk: A core determinant of lung fibrosis progressionChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  18. Light at night and lung cancer risk: A worldwide interdisciplinary and time-series studyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  19. Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivorsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  20. Omics approaches in asthma research: Challenges and opportunitiesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  21. Epithelial stem cells and niches in lung alveolar regeneration and diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  22. Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevanceChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  23. A crucial role of neutrophil extracellular traps in pulmonary infectious diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2024
  24. Advances in metabolomics of chronic obstructive pulmonary diseaseChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  25. Mechanisms of long COVID: An updated reviewChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  26. Asian, regional, and national burdens of respiratory tract cancers and associated risk factors from 1990 to 2019: A systematic analysis for the global burden of disease study 2019Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  27. Risk of extended viral shedding of Omicron BA.2 in Shanghai: Implications for vaccination strategy optimizationChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  28. Liquid biopsy for early detection of lung cancerChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  29. Pathogenesis, pathological characteristics and individualized therapy for immune-related adverse effectsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  30. Novel tools for early diagnosis and precision treatment based on artificial intelligenceChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  31. From gene identifications to therapeutic targets for asthma: Focus on great potentials of TSLP, ORMDL3, and GSDMBChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  32. Small airways in asthma: Pathophysiology, identification and managementChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  33. Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based studyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  34. Liver dysfunction on admission worsens clinical manifestations and outcomes of coronavirus disease 2019Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  35. Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatmentChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  36. Role of c-Myc in lung cancer: Progress, challenges, and prospectsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  37. Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancerChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  38. Early detection and prediction of acute exacerbation of chronic obstructive pulmonary diseaseChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  39. Positive sputum culture of Candida spp. as a risk factor for 30-day mortality in patients with hospital-acquired pneumonia: A propensity-score matched retrospective clinical studyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  40. Emerging roles and therapeutic implications of HDAC2 and IL-17A in steroid-resistant asthmaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  41. Low BMI patients with advanced EGFR mutation-positive NSCLC can get a better outcome from metformin plus EGFR-TKI as first-line therapy: A secondary analysis of a phase 2 randomized clinical trialChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  42. Twenty years of changes in the definition of early chronic obstructive pulmonary diseaseChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  43. TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseasesChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  44. Pyroptosis: A promising target for lung cancer therapyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  45. Robotic-assisted bronchoscopy in the diagnosis of peripheral pulmonary lesionsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  46. Epidemiology of coal miners’ pneumoconiosis and its social determinants: An ecological study from 1949 to 2021 in ChinaChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  47. Disparities in the global burden of tracheal, bronchus, and lung cancer from 1990 to 2019Chinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  48. HER3-targeted therapeutic antibodies and antibody–drug conjugates in non-small cell lung cancer refractory to EGFR-tyrosine kinase inhibitorsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  49. Taking early preventive interventions to manage the challenging issue of acquired resistance to third-generation EGFR inhibitorsChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023
  50. Targeting tumor microenvironment for non-small cell lung cancer immunotherapyChinese Medical Journal - Pulmonary and Critical Care Medicine · 2023